Living EuroGuiDerm Guideline for the systemic treatment of psoriasis vulgaris

 

The general recommendations developed in this guideline are based on the Living Cochrane review (https://pubmed.ncbi.nlm.nih.gov/35603936/). With new evidence and new results becoming available, the guideline development group will consider these and decide if and when an update is necessary. This will also be the case for the recommendations for specific clinical and comorbid situations.

 

 

Download entire guideline document in the latest version (2024):

Download
8145

Last updated
Changes
Download
Introduction, scoping, population and targeted users
09/2023
Editorial changes
Download
548
Disease severity and treatment goals
09/2023
No changes
Download
978
Methods and evidence section
09/2023
Editorial changes
Download
278
Main Recommendations and Decision Grid
09/2023
Deucravacitinib was added
Download
1373
Implementation slides
01/2024
New data added
Download
532
IFPA Guideline
09/2023
Editorial changes
Download
529

Last updated
Changes
Download
Acitretin
03/2023
No changes
Download
398
Ciclosporin
03/2023
Reference added
Download
329
Fumarates
03/2023
No changes
Download
160
Methotrexate
03/2023
New data added
Download
607
Adalimumab
03/2023
No changes
Download
286
Apremilast
03/2023
New data added
Download
343
Bimekizumab
09/2023
New data added
Download
247
Brodalumab
09/2023
New data added
Download
115
Certolizumab – Pegol
09/2023
No changes
Download
122
Deucravacitinib
03/2024
Editorial changes
Download
266
Etanercept
03/2023
No changes
Download
86
Guselkumab
03/2023
No changes
Download
235
Infliximab
03/2023
No changes
Download
103
Ixekizumab
09/2023
New data added
Download
180
Risankizumab
09/2023
New data added
Download
303
Secukinumab
09/2023
New data added
Download
200
Tildrakizumab
03/2023
No changes
Download
146
Ustekinumab
03/2023
No changes
Download
137
Biosimilars
09/2023
New data added
Download
118
Newly approved medications and treatments in the pipeline
10/2021
No changes
Download
266

Last updated
Changes
Download
Psoriatic arthritis
03/2023
New data added, recommendations changed
Download
444
Inflammatory bowel disease
10/2021
Recommendation concerning bimekizumab added
Download
178
Cancer
09/2023
New data added
Download
499
Depression
09/2023
New data added
Download
138
Diabetes Mellitus
09/2023
New data added, recommendations changed
Download
209
Heart disease
03/2023
New data added
Download
239
Kidney disease
03/2023
New data added
Download
127
Neurological diseases
09/2023
New data added
Download
142
Viral Hepatitis
01/2024
Chapter currently under review
Tuberculosis: Screening
09/2023
Editorial changes
Download
206
Tuberculosis: Treatment
09/2023
Editorial changes
Download
213
Wish for child / Pregnancy
10/2021
Time until pregnancy added for bimekizumab
Download
388
Vaccinations
03/2023
Completely new written
Download
271
Inmunogenicity
10/2021
No changes
Download
110

Last updated
Changes
Download
Methods Report
09/2023
Editorial changes
Download
225
Strength and limitations
09/2023
No changes
Download
73
Abbreviations
09/2023
Editorial changes
Download
34